<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">and </span>
   <span class="font16">with </span>
   <span class="font15">for </span>
   <span class="font15">patients </span>
   <span class="font15">TCBZ </span>
   <span class="font14">were </span>
   <span class="font14">fascioliasis </span>
   <span class="font14">The </span>
   <span class="font13">[]. </span>
   <span class="font13">treatment </span>
   <span class="font13">NTZ </span>
   <span class="font13">was </span>
   <span class="font12">{background </span>
   <span class="font12">human </span>
   <span class="font12">efficacy </span>
   <span class="font11">after </span>
   <span class="font11">cases </span>
   <span class="font11">margin </span>
   <span class="font11">are </span>
   <span class="font11">{border-style </span>
   <span class="font11">clinical </span>
   <span class="font11">triclabendazole </span>
   <span class="font11">Fasciola </span>
   <span class="font11">px;} </span>
   <span class="font11">study </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">has </span>
   <span class="font11">received </span>
   <span class="font11">failure </span>
   <span class="font11">Medicine </span>
   <span class="font11">hepatica </span>
   <span class="font11">not </span>
   <span class="font11">that </span>
   <span class="font11">this </span>
   <span class="font11">This </span>
   <span class="font11">acute </span>
   <span class="font11">been </span>
   <span class="font11">eosinophil </span>
   <span class="font11">Health </span>
   <span class="font11">Sciences </span>
   <span class="font11">have </span>
   <span class="font11">may </span>
   <span class="font11">response </span>
   <span class="font11">(.%) </span>
   <span class="font11">Egypt. </span>
   <span class="font11">including </span>
   <span class="font11">showed </span>
   <span class="font11">who </span>
   <span class="font11">Egypt </span>
   <span class="font11">Trop </span>
   <span class="font11">dose </span>
   <span class="font11">from </span>
   <span class="font11">resistance </span>
   <span class="font10">Patients </span>
   <span class="font10">between </span>
   <span class="font10">data </span>
   <span class="font10">fascioliasis. </span>
   <span class="font10">first </span>
   <span class="font10">group </span>
   <span class="font10">hepatic </span>
   <span class="font10">high </span>
   <span class="font10">which </span>
   <span class="font10">(%) </span>
   <span class="font10">Assiut </span>
   <span class="font10">However, </span>
   <span class="font10">Upper </span>
   <span class="font10">also </span>
   <span class="font10">chronic </span>
   <span class="font10">counts </span>
   <span class="font10">drug </span>
   <span class="font10">eosinophilia </span>
   <span class="font10">only </span>
   <span class="font10">Egypt, </span>
   <span class="font10">abdominal </span>
   <span class="font10">effective </span>
   <span class="font10">included </span>
   <span class="font10">its </span>
   <span class="font10">nitazoxanide </span>
   <span class="font10">non-responder </span>
   <span class="font10">px; </span>
   <span class="font10">studied </span>
   <span class="font10">{font-family </span>
   <span class="font10">Biology </span>
   <span class="font10">Fascioliasis </span>
   <span class="font10">Med </span>
   <span class="font10">Parasitol. </span>
   <span class="font10">adult </span>
   <span class="font10">based </span>
   <span class="font10">different </span>
   <span class="font10">disease </span>
   <span class="font10">drugs </span>
   <span class="font10">during </span>
   <span class="font10">eggs </span>
   <span class="font10">focal </span>
   <span class="font10">font-size </span>
   <span class="font10">infection </span>
   <span class="font10">initial </span>
   <span class="font10">positive </span>
   <span class="font10">signs </span>
   <span class="font10">stage </span>
   <span class="font10">studies </span>
   <span class="font10">study, </span>
   <span class="font10">./journal.pntd..tTable </span>
   <span class="font10">Cells </span>
   <span class="font10">Clinical </span>
   <span class="font10">Dis. </span>
   <span class="font10">Peru, </span>
   <span class="font10">Range </span>
   <span class="font10">TCBZ. </span>
   <span class="font10">against </span>
   <span class="font10">alternative </span>
   <span class="font10">clinical, </span>
   <span class="font10">conducted </span>
   <span class="font10">considered </span>
   <span class="font10">described </span>
   <span class="font10">double; </span>
   <span class="font10">fasciola </span>
   <span class="font10">follow </span>
   <span class="font10">followed </span>
   <span class="font10">improvement </span>
   <span class="font10">lesions </span>
   <span class="font10">liver </span>
   <span class="font10">non-responders </span>
   <span class="font10">other </span>
   <span class="font10">outbreak </span>
   <span class="font10">persistence </span>
   <span class="font10">radiological </span>
   <span class="font10">respond </span>
   <span class="font10">responder </span>
   <span class="font10">results </span>
   <span class="font10">stool </span>
   <span class="font10">study. </span>
   <span class="font10">symptoms </span>
   <span class="font10">test </span>
   <span class="font10">used </span>
   <span class="font10">(.%). </span>
   <span class="font10">ALT </span>
   <span class="font10">All </span>
   <span class="font10">Blood </span>
   <span class="font10">Department </span>
   <span class="font10">HFL </span>
   <span class="font10">Hyg. </span>
   <span class="font10">Life </span>
   <span class="font10">TCBZ(n </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Tropical </span>
   <span class="font10">University, </span>
   <span class="font10">WHO </span>
   <span class="font10">White </span>
   <span class="font10">age </span>
   <span class="font10">all </span>
   <span class="font10">among </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">control </span>
   <span class="font10">examination </span>
   <span class="font10">fascioliasis, </span>
   <span class="font10">had </span>
   <span class="font10">humans. </span>
   <span class="font10">month </span>
   <span class="font10">resistant </span>
   <span class="font10">resolution </span>
   <span class="font10">response. </span>
   <span class="font10">serological </span>
   <span class="font10">significantly </span>
   <span class="font10">solid; </span>
   <span class="font10">trials </span>
   <span class="font10">using </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.). </span>
   <span class="font10">AST </span>
   <span class="font10">Abdominal </span>
   <span class="font10">Although </span>
   <span class="font10">Cells: </span>
   <span class="font10">Data </span>
   <span class="font10">Egyptian </span>
   <span class="font10">Eosinophilia </span>
   <span class="font10">Eosinophils </span>
   <span class="font10">Faculty </span>
   <span class="font10">High </span>
   <span class="font10">Infect </span>
   <span class="font10">Laboratory </span>
   <span class="font10">Negl </span>
   <span class="font10">Nitazoxanide </span>
   <span class="font10">No. </span>
   <span class="font10">PLoS </span>
   <span class="font10">Signs </span>
   <span class="font10">Symptoms: </span>
   <span class="font10">These </span>
   <span class="font10">additional </span>
   <span class="font10">adults </span>
   <span class="font10">analysis </span>
   <span class="font10">before </span>
   <span class="font10">bold </span>
   <span class="font10">case </span>
   <span class="font10">children </span>
   <span class="font10">common </span>
   <span class="font10">compare </span>
   <span class="font10">complete </span>
   <span class="font10">courier; </span>
   <span class="font10">cure </span>
   <span class="font10">diagnosis </span>
   <span class="font10">did </span>
   <span class="font10">documented </span>
   <span class="font10">doses </span>
   <span class="font10">em; </span>
   <span class="font10">evaluate </span>
   <span class="font10">fascioliasis: </span>
   <span class="font10">few </span>
   <span class="font10">governorate </span>
   <span class="font10">group, </span>
   <span class="font10">infected </span>
   <span class="font10">infection, </span>
   <span class="font10">infections </span>
   <span class="font10">line </span>
   <span class="font10">low </span>
   <span class="font10">lower </span>
   <span class="font10">male </span>
   <span class="font10">management </span>
   <span class="font10">mean </span>
   <span class="font10">months </span>
   <span class="font10">most </span>
   <span class="font10">new </span>
   <span class="font10">nitazoxanide. </span>
   <span class="font10">observed </span>
   <span class="font10">partially </span>
   <span class="font10">patients, </span>
   <span class="font10">patients. </span>
   <span class="font10">peripheral </span>
   <span class="font10">present </span>
   <span class="font10">prospective </span>
   <span class="font10">pt;} </span>
   <span class="font10">public </span>
   <span class="font10">reported </span>
   <span class="font10">responded </span>
   <span class="font10">review </span>
   <span class="font10">stages </span>
   <span class="font10">such </span>
   <span class="font10">susceptibility </span>
   <span class="font10">titer </span>
   <span class="font10">treatment, </span>
   <span class="font10">trial </span>
   <span class="font10">triclabendazole. </span>
   <span class="font10">use </span>
  </p>
 </body>
</html>
